IQVIA
IQV
#602
Rank
โ‚น3.455 T
Marketcap
โ‚น20,290
Share price
0.41%
Change (1 day)
18.27%
Change (1 year)

Revenue for IQVIA (IQV)

Revenue in 2025 (TTM): โ‚น1.375 Trillion

According to IQVIA's latest financial reports the company's current revenue (TTM ) is โ‚น1.428 Trillion. In 2024 the company made a revenue of โ‚น1.321 Trillion an increase over the revenue in the year 2023 that were of โ‚น1.247 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for IQVIA from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น1.375 T4.07%
2024 โ‚น1.321 T5.94%
2023 โ‚น1.247 T4.61%
2022 โ‚น1.192 T15.47%
2021 โ‚น1.032 T24.31%
2020 โ‚น830.72 B5.06%
2019 โ‚น790.69 B8.61%
2018 โ‚น728.03 B16.85%
2017 โ‚น623.05 B33.3%
2016 โ‚น467.39 B22.58%
2015 โ‚น381.29 B10.19%
2014 โ‚น346.04 B9.84%
2013 โ‚น315.04 B18.26%
2012 โ‚น266.40 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
โ‚น12.49 B-99.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas